A detailed history of Simplex Trading, LLC transactions in Compugen LTD stock. As of the latest transaction made, Simplex Trading, LLC holds 603 shares of CGEN stock, worth $988. This represents 0.0% of its overall portfolio holdings.

Number of Shares
603
Previous 17,697 96.59%
Holding current value
$988
Previous $45,000 97.78%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$1.68 - $2.52 $28,717 - $43,076
-17,094 Reduced 96.59%
603 $1,000
Q1 2024

Apr 25, 2024

BUY
$1.75 - $2.95 $10,990 - $18,526
6,280 Added 55.01%
17,697 $45,000
Q4 2023

Feb 02, 2024

BUY
$0.53 - $2.0 $6,051 - $22,834
11,417 New
11,417 $22,000
Q2 2023

Aug 04, 2023

SELL
$0.57 - $1.38 $7,325 - $17,735
-12,852 Reduced 99.13%
113 $0
Q1 2023

Apr 27, 2023

SELL
$0.68 - $1.11 $1,022 - $1,668
-1,503 Reduced 10.39%
12,965 $9,000
Q4 2022

Feb 02, 2023

SELL
$0.58 - $1.2 $7,754 - $16,042
-13,369 Reduced 48.03%
14,468 $10,000
Q3 2022

Nov 04, 2022

SELL
$0.66 - $2.32 $837 - $2,944
-1,269 Reduced 4.36%
27,837 $18,000
Q2 2022

Aug 03, 2022

BUY
$1.57 - $3.33 $45,696 - $96,922
29,106 New
29,106 $53,000
Q1 2022

May 02, 2022

SELL
$2.76 - $4.64 $2,315 - $3,892
-839 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$4.09 - $7.16 $97,550 - $170,773
-23,851 Reduced 96.6%
839 $3,000
Q3 2021

Oct 28, 2021

SELL
$5.8 - $8.02 $27,126 - $37,509
-4,677 Reduced 15.93%
24,690 $197,000
Q2 2021

Aug 12, 2021

BUY
$6.87 - $9.16 $79,588 - $106,118
11,585 Added 65.15%
29,367 $243,000
Q1 2021

Apr 26, 2021

BUY
$7.67 - $13.77 $135,812 - $243,825
17,707 Added 23609.33%
17,782 $152,000
Q3 2020

Oct 14, 2020

SELL
$14.16 - $19.45 $15,236 - $20,928
-1,076 Reduced 93.48%
75 $1,000
Q2 2020

Jul 13, 2020

SELL
$6.97 - $17.12 $65,657 - $161,270
-9,420 Reduced 89.11%
1,151 $17,000
Q1 2020

Apr 29, 2020

BUY
$5.79 - $11.83 $10,670 - $21,802
1,843 Added 21.12%
10,571 $76,000
Q4 2019

Feb 05, 2020

SELL
$3.9 - $6.16 $79,189 - $125,078
-20,305 Reduced 69.94%
8,728 $52,000
Q3 2019

Oct 15, 2019

SELL
$3.01 - $4.49 $56,338 - $84,039
-18,717 Reduced 39.2%
29,033 $122,000
Q2 2019

Jul 26, 2019

BUY
$2.8 - $4.14 $88,547 - $130,923
31,624 Added 196.11%
47,750 $183,000
Q1 2019

Apr 18, 2019

BUY
$2.35 - $4.19 $35,677 - $63,612
15,182 Added 1608.26%
16,126 $0
Q4 2018

Jan 16, 2019

SELL
$2.17 - $3.8 $53,946 - $94,468
-24,860 Reduced 96.34%
944 $2,000
Q3 2018

Oct 23, 2018

BUY
$3.0 - $4.05 $38,010 - $51,313
12,670 Added 96.47%
25,804 $99,000
Q2 2018

Jul 30, 2018

SELL
$3.15 - $4.7 $63,255 - $94,380
-20,081 Reduced 60.46%
13,134 $43,000
Q1 2018

Apr 26, 2018

BUY
$2.5 - $4.45 $39,340 - $70,025
15,736 Added 90.03%
33,215 $147,000
Q4 2017

Jan 10, 2018

BUY
$2.35 - $4.0 $40,450 - $68,852
17,213 Added 6471.05%
17,479 $43,000
Q3 2017

Oct 25, 2017

BUY
$2.75 - $3.95 $731 - $1,050
266
266 $1,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.